Aurora Cannabis Inc. ($ACB) Stock Forecast: Down 5.0% Today

What is Aurora Cannabis Inc.?

Aurora Cannabis (NASDAQ: ACB) is a prominent Canadian cannabis company recognized for its medical and recreational marijuana products. The stock's volatility is influenced by regulatory changes and market fluctuations in the cannabis industry.

Why is Aurora Cannabis Inc. going down?

ACB stock is down 5.0% on Jan 29, 2026 16:12

• The recent "buy" rating from Canaccord Genuity Group may have initially boosted investor sentiment, but the subsequent stock price decline suggests potential concerns regarding Aurora Cannabis's profitability and revenue performance.
• While surpassing earnings per share (EPS) expectations, missing revenue estimates could have eroded investor confidence, contributing to the sell-off.
• Varying analyst ratings and active trading by institutional investors indicate uncertainty and potential profit-taking, intensifying the downward pressure on the stock.
• Aurora Cannabis's overall decline may stem from reevaluations of its financial well-being and growth prospects in the competitive cannabis sector, overshadowing any positive market performance on Thursday.

ACB Price Chart

ACB Technical Analysis

ACB News

Aurora Cannabis (NASDAQ:ACB) Now Covered by Canaccord Genuity Group

Canaccord Genuity Group has initiated coverage on Aurora Cannabis (NASDAQ:ACB) with a "buy" rating. This comes as Aurora Cannabis reported quarterly earnings that beat estimates but missed revenue forecasts, with the company remaining unprofitable. Institutional investors hold a significant portion of the stock, and its share price has fluctuated within a 52-week range of $3.42–$6.91.

https://www.marketbeat.com/instant-alerts/aurora-cannabis-nasdaqacb-now-covered-by-canaccord-genuity-group-2026-01-27/

Aurora Cannabis (NASDAQ:ACB) Stock Price Down 2.5% - Here's Why

Aurora Cannabis (NASDAQ:ACB) shares dropped 2.5% during mid-day trading on Monday, with trading volume significantly below average. Analysts offer mixed ratings for the stock, though the consensus is "Hold." The company recently beat EPS estimates but missed revenue expectations, and institutional investors have been actively trading its shares.

https://www.marketbeat.com/instant-alerts/aurora-cannabis-nasdaqacb-stock-price-down-25-heres-why-2026-01-27/

Aurora Cannabis Inc. Stock Rises Thursday, Outperforms Market

Aurora Cannabis Inc. (ACB) saw its stock rise by 2.31% on Thursday, outperforming the broader market. This article briefly mentions Aurora Cannabis's stock performance and then transitions into a report on Unity Software's (U.US) fourth-quarter financial results, which showed a significant revenue increase but also a quarterly loss per share.

https://news.futunn.com/en/post/67784314/aurora-cannabis-inc-stock-rises-thursday-outperforms-market

Trending Today

Ethereum ($ETH) Crypto Forecast: Down 5.5% Today

Reddit Inc ($RDDT) Stock Forecast: Down 5.1% Today

Rivian Automotive Inc. ($RIVN) Stock Forecast: Down 5.5% Today

Marathon Digital Holdings Inc. ($MARA) Stock Forecast: Down 5.1% Today

AT&T Inc. ($T) Stock Forecast: Up 5.0% Today

Shopify Inc. Class A Subordinate ($SHOP) Stock Forecast: Down 5.1% Today

Charter Communications Inc. ($CHTR) Stock Forecast: Up 9.0% Today

Air Products and Chemicals Inc. ($APD) Stock Forecast: Up 5.4% Today

Albemarle Corporation ($ALB) Stock Forecast: Down 6.3% Today

Freeport-McMoRan Inc. ($FCX) Stock Forecast: Down 8.4% Today

Aurora Cannabis Inc. Price History

21.00.2026 - ACB Stock was up 4.1%

• The surge in Aurora Cannabis Inc. (ACB) stock today is linked to the company obtaining Community Plant Variety Rights in the EU for its cannabis varieties, 'Farm Gas' and 'Sourdough'. This move reinforces Aurora's market position and underscores its dedication to innovative and high-quality products.
• Gaining exclusive rights for the commercial production and distribution of these potent cannabis strains across the EU's 27 member states marks a significant milestone that is likely to enhance investor confidence in Aurora's growth potential.
• Furthermore, the potential implications of President Trump's executive order to reclassify cannabis to Schedule 3, potentially easing the tax burden under Section 280E for U.S. cannabis companies, could have also influenced the positive outlook on Aurora Cannabis and the broader cannabis sector.

22.11.2025 - ACB Stock was down 5.3%

• ACB stock experienced a bearish movement despite the positive news of launching its Daily Special™ medical cannabis brand in Germany.
• The underperformance in the market could be attributed to profit-taking by investors after a recent strong performance in Q2 2025 and market expansions in Poland and Australia.
• The projected boom in the cannabis beverage market might have raised concerns about increased competition for ACB, leading to a sell-off in the stock.
• Investors might be cautious about the company's ability to maintain its market share in Germany amidst the growing competition and expanding applications in the cannabis industry.

17.11.2025 - ACB Stock was up 11.7%

• ACB experienced a strong bullish movement of 20.0% driven by reports of potential easing of U.S. marijuana restrictions under President Trump, signaling positive sentiment and optimism in the cannabis sector.
• The stock surge was also influenced by ACB's international expansion efforts in Europe and Australia, indicating a strategic approach to capitalize on new market opportunities.
• Despite concerns over negative profitability margins, the stock's valuation metrics suggest potential undervaluation, attracting investor interest and leading to a surge in call options trading volume.
• The outlook for ACB remains cautiously optimistic, with market volatility and regulatory dynamics posing potential risks despite the bullish trends fueled by favorable political developments.

29.00.2026 - ACB Stock was down 5.0%

• The recent "buy" rating from Canaccord Genuity Group may have initially boosted investor sentiment, but the subsequent stock price decline suggests potential concerns regarding Aurora Cannabis's profitability and revenue performance.
• While surpassing earnings per share (EPS) expectations, missing revenue estimates could have eroded investor confidence, contributing to the sell-off.
• Varying analyst ratings and active trading by institutional investors indicate uncertainty and potential profit-taking, intensifying the downward pressure on the stock.
• Aurora Cannabis's overall decline may stem from reevaluations of its financial well-being and growth prospects in the competitive cannabis sector, overshadowing any positive market performance on Thursday.

29.08.2025 - ACB Stock was up 6.0%

• The implied volatility surging for Aurora Cannabis stock options indicates a heightened interest and activity in the options market, potentially leading to increased buying pressure on the stock.
• This surge in implied volatility could suggest that investors are anticipating significant price movements in ACB stock, leading to a bullish momentum in the market.
• The increased attention from investors in the options market may be driven by positive news or developments surrounding Aurora Cannabis, contributing to the strong bullish movement observed in the stock today.

29.08.2025 - ACB Stock was up 4.4%

• There was a notable bullish movement in the stock of ACB today.
• Positive sentiment within the cannabis industry was sparked by President Trump's public endorsement of the potential health benefits of cannabis on social media.
• Increased interest from investors and potential speculation on future price changes is reflected in the surge of implied volatility for ACB stock options.
• The surge in ACB stock price was likely influenced by a combination of Trump's supportive stance on cannabis and the heightened activity in options trading.

16.11.2025 - ACB Stock was up 5.1%

• Aurora Cannabis (ACB) stock spiked by 20.0% due to rumors of potential easing of US marijuana regulations, reflecting investor confidence in the sector's future profitability.
• The rise in Aurora's stock price was also supported by the company's deliberate international expansions in Europe and Australia, signaling positive growth prospects.
• A notable increase in the trading volume of call options for ACB indicates growing investor interest and belief in the stock's potential upside, despite concerns about profitability margins.
• Expectations of policy shifts and the possible reclassification of marijuana as a Schedule III substance under the Trump administration fostered a positive market sentiment, driving a bullish trend for Aurora Cannabis and the broader cannabis industry.

12.11.2025 - ACB Stock was up 10.1%

• The increase in ACB stock value today is linked to the company's strategic expansion of its medical cannabis portfolio through the introduction of Black Jelly in Poland, allowing access to one of Europe's fastest-growing markets.
• The launch of a new proprietary high-potency medical cannabis strain, with a THC content of 27% and cultivated in Aurora's advanced facilities, highlights the company's dedication to meeting the demand for premium medical cannabis products.
• Despite financial difficulties and concerns about potential bankruptcy, the favorable market reception to Aurora's product expansion demonstrates investor confidence in the company's capability to capitalize on its expertise in global markets and effectively address patient and prescriber requirements.

12.11.2025 - ACB Stock was up 15.1%

• ACB stock experienced a strong bullish movement today, rallying approximately 15% in pre-market trading.
• The surge was fueled by considerations around the reclassification of marijuana as a Schedule III drug, potentially easing penalties and tax burdens for cannabis companies.
• The launch of a new high-potency medical cannabis product, Black Jelly, in Poland also contributed to the positive market sentiment and reinforced Aurora's leadership in the international medical cannabis market.
• Despite facing financial challenges and bankruptcy risks, Aurora's strategic expansions and product innovations continue to attract investors and drive the stock price higher.

08.07.2025 - ACB Stock was up 5.1%

• ACB stock experienced a strong bullish movement despite Q1 earnings missing estimates, showcasing resilience in the face of challenges.
• The 17.5% year-over-year revenue growth indicates the company's ability to capitalize on the strong global medical cannabis demand.
• Investors seem optimistic about ACB's future potential, as the stock beat revenue estimates despite reporting a loss, hinting at long-term growth prospects.
• Despite near-term regulatory headwinds impacting Q1 revenue, ACB's solid global medical cannabis momentum suggests a promising outlook for the stock.

19.11.2025 - ACB Stock was down 12.0%

• The bearish movement in ACB's stock price today could be attributed to profit-taking by investors after the recent 8.2% surge driven by speculation of potential easing of cannabis restrictions under President Trump.
• Despite the launch of the Daily Special™ medical cannabis brand in Germany, which aimed to offer high-quality, affordable options and strengthen Aurora's position in the market, investors may have reacted cautiously due to concerns about the company's financial health, including negative profitability and free cash flow loss.
• The overall bearish sentiment towards ACB today might also be influenced by broader market dynamics or sector-specific trends impacting the cannabis industry as a whole, leading to a temporary pullback in the stock price.

29.11.2025 - ACB Stock was down 5.3%

• ACB stock experienced a bearish movement, sliding by 1.72% and underperforming the market.
• The underperformance could be attributed to overall market sentiment towards the cannabis sector or company-specific factors.
• The mention of Unity Software's strong financial results in a recent communication may have inadvertently highlighted ACB's own underwhelming performance, leading to a further decline in its stock price.
• Investors may have reacted negatively to the quarterly loss reported by Unity Software, potentially signaling concerns about profitability in the tech sector, which could have spilled over to impact ACB's stock negatively.